scholarly article | Q13442814 |
P2093 | author name string | Wolters M | |
Schmitt B | |||
Lichtinghagen R | |||
Stichtenoth DO | |||
Hahn A | |||
Kelb K | |||
Mang B | |||
P2860 | cites work | Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces | Q28168554 |
Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity | Q30887130 | ||
A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes | Q33954068 | ||
Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential | Q34401363 | ||
Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro | Q34423596 | ||
Treatment of diabetic dyslipoproteinemia | Q35210034 | ||
Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes | Q35634210 | ||
Lipoprotein abnormalities and their consequences for patients with type 2 diabetes | Q35675497 | ||
Cinnamate Supplementation Enhances Hepatic Lipid Metabolism and Antioxidant Defense Systems in High Cholesterol-Fed Rats | Q44636499 | ||
Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats | Q44660795 | ||
Cinnamon extract prevents the insulin resistance induced by a high-fructose diet | Q44787310 | ||
Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. | Q54122498 | ||
Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. | Q55033730 | ||
P433 | issue | 5 | |
P921 | main subject | lipid | Q11367 |
type 2 diabetes | Q3025883 | ||
glucose | Q37525 | ||
P304 | page(s) | 340-344 | |
P577 | publication date | 2006-05-01 | |
P1433 | published in | European Journal of Clinical Investigation | Q15745208 |
P1476 | title | Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. | |
P478 | volume | 36 |
Q35788349 | A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial |
Q35112068 | A high antioxidant spice blend attenuates postprandial insulin and triglyceride responses and increases some plasma measures of antioxidant activity in healthy, overweight men. |
Q38309138 | A review of the benefits of Satureja species on metabolic syndrome and their possible mechanisms of action. |
Q36766202 | A review of the hypoglycemic effects of five commonly used herbal food supplements |
Q34581718 | Acute effect of Ceylon cinnamon extract on postprandial glycemia: alpha-amylase inhibition, starch tolerance test in rats, and randomized crossover clinical trial in healthy volunteers |
Q34237460 | Adjunctive naturopathic care for type 2 diabetes: patient-reported and clinical outcomes after one year |
Q37995313 | An evidence-based systematic review of cinnamon (Cinnamomum spp.) by the Natural Standard Research Collaboration |
Q40325158 | Anti-diabetic and antioxidant effect of cinnamon in poorly controlled type-2 diabetic Iraqi patients: A randomized, placebo-controlled clinical trial |
Q28504944 | Anti-obesity and anti-hyperglycemic effects of cinnamaldehyde via altered ghrelin secretion and functional impact on food intake and gastric emptying |
Q90419939 | Antidiabetic Potential of Medicinal Plants and Their Active Components |
Q90149178 | Antioxidant Effects and Mechanisms of Medicinal Plants and Their Bioactive Compounds for the Prevention and Treatment of Type 2 Diabetes: An Updated Review |
Q45943326 | Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. |
Q36433359 | Assessment of the effeCt of lIfestyle iNtervention plus water-soluble ciNnAMon extract On loweriNg blood glucose in pre-diabetics, a randomized, double-blind, multicenter, placebo controlled trial: study protocol for a randomized controlled trial |
Q52841999 | Attenuation of glucose transport across Caco-2 cell monolayers by a polyphenol-rich herbal extract: interactions with SGLT1 and GLUT2 transporters. |
Q24234529 | Ayurvedic treatments for diabetes mellitus |
Q38203277 | Beneficial effects of cinnamon on the metabolic syndrome, inflammation, and pain, and mechanisms underlying these effects - a review |
Q37946916 | Bioactivity of cinnamon with special emphasis on diabetes mellitus: a review |
Q34266920 | Cassia cinnamon does not change the insulin sensitivity or the liver enzymes in subjects with impaired glucose tolerance |
Q51007592 | Ceylon cinnamon does not affect postprandial plasma glucose or insulin in subjects with impaired glucose tolerance. |
Q46153156 | Changes in glucose tolerance and insulin sensitivity following 2 weeks of daily cinnamon ingestion in healthy humans. |
Q39010791 | Chicory inulin ameliorates type 2 diabetes mellitus and suppresses JNK and MAPK pathways in vivo and in vitro |
Q46782933 | Chromium and polyphenols from cinnamon improve insulin sensitivity |
Q42427198 | Chronic administration of a combination of six herbs inhibits the progression of hyperglycemia and decreases serum lipids and aspartate amino transferase activity in diabetic rats |
Q37061132 | Cinnamaldehyde Attenuates Cataractogenesis via Restoration of Hypertension and Oxidative Stress in Fructose-Fed Hypertensive rats |
Q37726319 | Cinnamon Polyphenol Extract Inhibits Hyperlipidemia and Inflammation by Modulation of Transcription Factors in High-Fat Diet-Fed Rats |
Q89278021 | Cinnamon and Cassia Nomenclature Confusion: A Challenge to the Applicability of Clinical Data |
Q38988547 | Cinnamon and Chronic Diseases. |
Q37798207 | Cinnamon and health |
Q46385685 | Cinnamon as possible treatment of diabetes mellitus type 2 |
Q37570870 | Cinnamon effects on metabolic syndrome: a review based on its mechanisms |
Q28659092 | Cinnamon extract enhances glucose uptake in 3T3-L1 adipocytes and C2C12 myocytes by inducing LKB1-AMP-activated protein kinase signaling |
Q51354665 | Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes. |
Q37345991 | Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose |
Q24200805 | Cinnamon for diabetes mellitus |
Q36818086 | Cinnamon in diabetes mellitus |
Q36768273 | Cinnamon supplementation in patients with type 2 diabetes mellitus |
Q27022291 | Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis |
Q37730745 | Cinnamon: a multifaceted medicinal plant |
Q33979747 | Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes |
Q37581455 | Comparing GWAS Results of Complex Traits Using Full Genetic Model and Additive Models for Revealing Genetic Architecture |
Q24648508 | Complementary and alternative medicine for the treatment of type 2 diabetes |
Q37957472 | Controversies surrounding the clinical potential of cinnamon for the management of diabetes |
Q34540095 | Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review |
Q50686924 | Effect of Cinnamomum zeylanicum extract on scopolamine-induced cognitive impairment and oxidative stress in rats. |
Q35894476 | Effect of Cinnamon Tea on Postprandial Glucose Concentration |
Q33791991 | Effect of oral cinnamon intervention on metabolic profile and body composition of Asian Indians with metabolic syndrome: a randomized double -blind control trial |
Q41898669 | Effects of Cinnamon Consumption on Glycemic Indicators, Advanced Glycation End Products, and Antioxidant Status in Type 2 Diabetic Patients |
Q36249402 | Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women |
Q39642799 | Effects of cinnamaldehyde on the glucose transport activity of GLUT1 |
Q36195536 | Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients. |
Q34699762 | Effects of short-term cinnamon ingestion on in vivo glucose tolerance. |
Q51318521 | Effects of the polyphenol content on the anti-diabetic activity of Cinnamomum zeylanicum extracts. |
Q34667459 | Evaluation of a novel supplement to reduce blood glucose through the use of a modified oral glucose tolerance test. |
Q92591852 | Evaluation of relaxant responses properties of cinnamon essential oil and its major component, cinnamaldehyde on human and rat corpus cavernosum |
Q46928863 | Evaluation of six plant species used traditionally in the treatment and control of diabetes mellitus in South Africa using in vitro methods |
Q87624365 | Evaluation of the in vitro anti-hyperglycemic effect of Cinnamomum cassia derived phenolic phytochemicals, via carbohydrate hydrolyzing enzyme inhibition |
Q37027211 | From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark |
Q64098043 | Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity |
Q28087696 | How effective are antioxidant supplements in obesity and diabetes? |
Q37014815 | Improved Insulin Resistance and Lipid Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator-Activated Receptors |
Q53080760 | In vitro and in vivo safety studies of cinnamon extract (Cinnamomum cassia) on general and genetic toxicology. |
Q26739475 | New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease |
Q28253535 | New identification of proanthocyanidins in cinnamon (Cinnamomum zeylanicum L.) using MALDI-TOF/TOF mass spectrometry |
Q38369231 | Nutritional intervention and impact of polyphenol on glycohemoglobin (HbA1c) in non-diabetic and type 2 diabetic subjects: Systematic review and nmeta-analysis |
Q37620455 | Nutritional supplements and serum lipids: does anything work? |
Q34162991 | Nutritional supplements and their effect on glucose control |
Q49992717 | Optimizing Non-Pharmacologic Management of Hypertriglyceridemia |
Q48269956 | Phenolic compounds as natural and multifunctional anti-obesity agents: A review |
Q37128203 | Plant-derived therapeutics for the treatment of metabolic syndrome |
Q37060111 | Polycystic ovary syndrome (PCOS) and other androgen excess-related conditions: can changes in dietary intake make a difference? |
Q60920058 | Polyherbal dietary supplementation for prediabetic adults: study protocol for a randomized controlled trial |
Q26770277 | Polyphenols and Glycemic Control |
Q36730997 | Potential therapeutic value of TRPV1 and TRPA1 in diabetes mellitus and obesity |
Q37604039 | Potential treatments for insulin resistance in the horse: a comparative multi-species review |
Q61448039 | Probiotic assisted weight management as a main factor for glycemic control in patients with type 2 diabetes: a randomized controlled trial |
Q90055416 | Protective effects of 2-methoxycinnamaldehyde an active ingredients of Cinnamomum cassia on warm hepatic ischemia reperfusion injury in rat model |
Q90573346 | Role of medicinal plants in the management of diabetes mellitus: a review |
Q36078113 | Some pharmacological effects of cinnamon and ginger herbs in obese diabetic rats |
Q26739958 | TRP Channels as Therapeutic Targets in Diabetes and Obesity |
Q38140726 | Tackling metabolic syndrome by functional foods |
Q35129349 | Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals |
Q34661198 | The Effect of Cinnamon on Glucose of Type II Diabetes Patients. |
Q57811285 | The effect of cinnamon on polycystic ovary syndrome in a mouse model |
Q26782181 | The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials |
Q27011434 | The use of complementary and alternative medicines (CAMs) in the treatment of diabetes mellitus: is continued use safe and effective? |
Q24657961 | Traditional chinese medicine in treatment of metabolic syndrome |
Q41025468 | Treatment of Diabetes Mellitus Using iPS Cells and Spice Polyphenols |
Q37151590 | Trimer procyanidin oligomers contribute to the protective effects of cinnamon extracts on pancreatic β-cells in vitro |
Q94150267 | Turmeric, Pepper, Cinnamon, and Saffron Consumption and Mortality |
Q48143447 | Use of complementary and alternative medicine supplements in patients with diabetes mellitus |
Search more.